Opicapone

Overview

Opicapone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1089318).

API suppliers (1)

Suppliers of Opicapone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• BIAL PORTELA AND CA SA2 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Opicapone expires 12 Dec 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol

Canonical SMILES

CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-]

InChIKey

ASOADIZOVZTJSR-UHFFFAOYSA-N